Avantor Investor Day Presentation Deck

Integrated Go-To-Market Leveraging R&D access to seed proprietary Biopharma offering BIOPHARMA PLATFORMS BASIC RESEARCH & DRUG DISCOVERY R&D SOURCES OUTCOMES: - Broad access to R&D through commercial reach Vavantor Navantor™ THERAPEUTIC AREAS Bioproduction products in lab scale configurations Opportunities to seed Bioproduction products early in drug discovery CLINICAL TRIALS & SCALE UP 2 O Regulatory expertise and GMP products Avantor products specified into products and processes - COMMERCIAL MANUFACTURING GMP products in bulk configuration 3 - Biopharma process optimization expertise Long-term, recurring revenue across multiple drugs 34

View entire presentation